From the Research
Yes, adults can get coxsackievirus infections, which can lead to severe complications such as myocarditis, dilated cardiomyopathy, and even death, as reported in a recent study 1. The coxsackievirus infection in adults can manifest with symptoms including fever, sore throat, headache, muscle aches, and in some cases, a rash or blisters on the hands, feet, and mouth. Most coxsackievirus infections in adults are mild and resolve on their own within 7-10 days without specific treatment. However, adults with weakened immune systems may experience more severe symptoms and complications, such as persistent high fever, difficulty breathing, chest pain, or severe headache, which can be life-threatening if left untreated 2, 3. Management of coxsackievirus infection in adults typically involves rest, adequate hydration, and over-the-counter pain relievers like acetaminophen or ibuprofen to manage fever and discomfort. Recently, a novel antiviral compound, ethyl 3-hydroxyhexanoate, has been found to have potent antiviral activity against coxsackievirus B infection, which may provide a promising therapeutic option for the treatment of coxsackievirus-related infections in adults 4. Good hygiene practices, including frequent handwashing, are essential for preventing the spread of coxsackievirus infection. Adults should seek medical attention immediately if they experience severe symptoms or have a weakened immune system, as prompt treatment can significantly improve outcomes and reduce the risk of complications and mortality. Some key points to consider in the management of coxsackievirus infection in adults include:
- Rest and adequate hydration to help the body recover from the infection
- Over-the-counter pain relievers like acetaminophen or ibuprofen to manage fever and discomfort
- Good hygiene practices, including frequent handwashing, to prevent the spread of the virus
- Seeking medical attention immediately if severe symptoms or complications occur
- Considering novel antiviral compounds, such as ethyl 3-hydroxyhexanoate, as a potential therapeutic option for the treatment of coxsackievirus-related infections.